Association of Monocyte Tumor Necrosis Factor α Expression and Serum Inflammatory Biomarkers with Walking Impairment in Peripheral Artery Disease

Overview

Journal J Vasc Surg

Publisher Elsevier

Specialties Cardiology & Vascular Diseases
General Surgery

Date 2014 Aug 7

PMID 25095746

Citations 27

Authors

Reena L Pande

Jonathan Brown

Stewart Buck

Whitney Redline

Jeanne Doyle

Jorge Plutzky

Mark A Creager

Affiliations

Soon will be listed here.

Abstract

Objective: Inflammation contributes to the development of peripheral artery disease (PAD) and may contribute to intermittent claudication by adversely affecting vascular and skeletal muscle function. We explored the association of inflammation to maximal walking time (MWT) in patients with claudication.

Methods: Circulating inflammatory biomarkers, including tumor necrosis factor α (TNF-α), C-reactive protein (CRP), interleukin-6 (IL-6), and soluble intercellular adhesion molecule 1 (sICAM), were measured in 75 subjects with intermittent claudication as well as in 43 healthy subjects. Real-time polymerase chain reaction was used to quantify mRNA expression of TNF-α, IL-6, interferon-γ, and CD36 from peripheral blood monocytes. Treadmill testing was performed in PAD subjects to assess MWT.

Results: Compared with healthy subjects, PAD subjects had higher levels of circulating TNF-α (P < .0001), CRP (P = .003), sICAM (P < .0001), and IL-6 (P < .0001). Expression of both IL-6 (P = .024) and CD36 (P = .018) was greater in PAD subjects than in healthy subjects. Among subjects with PAD, higher gene expression of TNF-α was associated inversely with MWT (P = .01). MWT was also associated inversely with greater levels of circulating TNF-α (P = .028), CRP (P = .024), IL-6 (P = .03), and sICAM (P = .018).

Conclusions: Systemic inflammation, as indicated by TNF-α inflammatory gene expression in peripheral blood monocytes and by circulating biomarker levels, is associated with impairment in walking time in patients with PAD and intermittent claudication.

Citing Articles

Prediction of Major Adverse Limb Events in Females with Peripheral Artery Disease using Blood-Based Biomarkers and Clinical Features.

Li B, Khan H, Shaikh F, Zamzam A, Abdin R, Qadura M J Cardiovasc Transl Res. 2024; .

PMID: 39643751 DOI: 10.1007/s12265-024-10574-y.

The Predictive Role of Inflammatory Biomarkers and Their Correlation with the Biochemical Profile in Patients with Vasculopathy Undergoing Surgery.

Akacsos-Szasz O, Pal S, Nyulas K, Szilveszter M, Simon-Szabo Z, Denes L Int J Mol Sci. 2024; 25(22).

PMID: 39596058 PMC: 11593650. DOI: 10.3390/ijms252211989.

Novel Plasma Biomarkers Associated with Future Peripheral Atherosclerotic Disease and Abdominal Aortic Aneurysm-Insights from Contemporary Prospective Studies from the Malmö Diet and Cancer Study.

Acosta S, Fatemi S, Zarrouk M, Gottsater A Biomolecules. 2024; 14(7).

PMID: 39062558 PMC: 11275106. DOI: 10.3390/biom14070844.

An evaluation of inflammatory and endothelial dysfunction markers as determinants of peripheral arterial disease in those with diabetes mellitus.

Zaib S, Ahmad S, Khan I, Bin Jardan Y, Wondmie G Sci Rep. 2024; 14(1):15348.

PMID: 38961103 PMC: 11222457. DOI: 10.1038/s41598-024-65188-w.

Multi-Modality Imaging of Atheromatous Plaques in Peripheral Arterial Disease: Integrating Molecular and Imaging Markers.

Wang X, Nai Y, Gan J, Lian C, Ryan F, Tan F Int J Mol Sci. 2023; 24(13).

PMID: 37446302 PMC: 10342137. DOI: 10.3390/ijms241311123.

References

Pande R, Hiatt W, Zhang P, Hittel N, Creager M . A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med. 2010; 15(3):181-8. PMC: 2883185. DOI: 10.1177/1358863X10361545. View

Venables M, Jeukendrup A . Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabetes Metab Res Rev. 2009; 25 Suppl 1:S18-23. DOI: 10.1002/dmrr.983. View

Brevetti G, Giugliano G, Brevetti L, Hiatt W . Inflammation in peripheral artery disease. Circulation. 2010; 122(18):1862-75. DOI: 10.1161/CIRCULATIONAHA.109.918417. View

Hirsch A, Haskal Z, Hertzer N, Bakal C, Creager M, Halperin J . ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for.... Circulation. 2006; 113(11):e463-654. DOI: 10.1161/CIRCULATIONAHA.106.174526. View

McDermott M, Greenland P, Green D, Guralnik J, Criqui M, Liu K . D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation. 2003; 107(25):3191-8. DOI: 10.1161/01.CIR.0000074227.53616.CC. View

Hamburg N, McMackin C, Huang A, Shenouda S, Widlansky M, Schulz E . Physical inactivity rapidly induces insulin resistance and microvascular dysfunction in healthy volunteers. Arterioscler Thromb Vasc Biol. 2007; 27(12):2650-6. PMC: 2596308. DOI: 10.1161/ATVBAHA.107.153288. View

Mohler 3rd E, Hiatt W, Creager M . Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003; 108(12):1481-6. DOI: 10.1161/01.CIR.0000090686.57897.F5. View

Andreozzi G, Martini R, Cordova R, DEri A, Salmistraro G, Mussap M . Circulating levels of cytokines (IL-6 and IL-1beta) in patients with intermittent claudication, at rest, after maximal exercise treadmill test and during restore phase. Could they be progression markers of the disease?. Int Angiol. 2007; 26(3):245-52. View

Edwards A, Blann A, Lardi A, McCollum C . Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg. 1994; 81(12):1738-41. DOI: 10.1002/bjs.1800811211. View

10.

Hevener A, Olefsky J, Reichart D, Audrey Nguyen M, Bandyopadyhay G, Leung H . Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest. 2007; 117(6):1658-69. PMC: 1868788. DOI: 10.1172/JCI31561. View

11.

Beckman J, Preis O, Ridker P, Gerhard-Herman M . Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol. 2005; 96(10):1374-8. DOI: 10.1016/j.amjcard.2005.07.041. View

12.

Alibegovic A, Sonne M, Hojbjerre L, Bork-Jensen J, Jacobsen S, Nilsson E . Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men. Am J Physiol Endocrinol Metab. 2010; 299(5):E752-63. DOI: 10.1152/ajpendo.00590.2009. View

13.

Visser M, Pahor M, Taaffe D, Goodpaster B, Simonsick E, Newman A . Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002; 57(5):M326-32. DOI: 10.1093/gerona/57.5.m326. View

14.

Owens C, Ridker P, Belkin M, Hamdan A, Pomposelli F, LoGerfo F . Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg. 2006; 45(1):2-9. PMC: 3488442. DOI: 10.1016/j.jvs.2006.08.048. View

15.

Vidula H, Tian L, Liu K, Criqui M, Ferrucci L, Pearce W . Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med. 2008; 148(2):85-93. PMC: 2653260. DOI: 10.7326/0003-4819-148-2-200801150-00003. View

16.

Wildman R, Muntner P, Chen J, Sutton-Tyrrell K, He J . Relation of inflammation to peripheral arterial disease in the national health and nutrition examination survey, 1999-2002. Am J Cardiol. 2005; 96(11):1579-83. DOI: 10.1016/j.amjcard.2005.07.067. View

17.

Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C . Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998; 97(5):425-8. DOI: 10.1161/01.cir.97.5.425. View

18.

Ridker P, Stampfer M, Rifai N . Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001; 285(19):2481-5. DOI: 10.1001/jama.285.19.2481. View

19.

Bregar U, Poredos P, Sabovic M, Jug B, Sebestjen M . The influence of atorvastatin on walking performance in peripheral arterial disease. Vasa. 2009; 38(2):155-9. DOI: 10.1024/0301-1526.38.2.155. View

20.

Craft L, Guralnik J, Ferrucci L, Liu K, Tian L, Criqui M . Physical activity during daily life and circulating biomarker levels in patients with peripheral arterial disease. Am J Cardiol. 2008; 102(9):1263-8. PMC: 3404486. DOI: 10.1016/j.amjcard.2008.06.051. View